The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding shareholders.
Identifying the best companies in the S&P 500 isn’t always easy, and that’s why we started StockStory. Keeping that in mind, here are three S&P 500 stocks leading the market forward.
Coinbase (COIN)
Market Cap: $83.24 billion
Widely regarded as the face of crypto, Coinbase (NASDAQ:COIN) is a blockchain infrastructure company updating the financial system with its trading, staking, stablecoin, and other payment solutions.
Why Will COIN Outperform?
- 56.8% annual increases in its average revenue per user over the last two years show its platform is resonating with power users
- Earnings growth has massively outpaced its peers over the last two years as its EPS has compounded at 96.4% annually
- COIN is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its rising cash conversion increases its margin of safety
Coinbase’s stock price of $325.50 implies a valuation ratio of 27.1x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Super Micro (SMCI)
Market Cap: $26.12 billion
Founded in Silicon Valley in 1993 and known for its modular "building block" approach to server design, Super Micro Computer (NASDAQ:SMCI) designs and manufactures high-performance, energy-efficient server and storage systems for data centers, cloud computing, AI, and edge computing applications.
Why Are We Bullish on SMCI?
- Market share has increased this cycle as its 75.6% annual revenue growth over the last two years was exceptional
- Dominant market position is represented by its $21.97 billion in revenue and gives it fixed cost leverage when sales grow
- Free cash flow margin is now positive, showing the company is at an important crossroads
Super Micro is trading at $45.73 per share, or 15.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Abbott Laboratories (ABT)
Market Cap: $230.9 billion
With roots dating back to 1888 when founder Dr. Wallace Abbott began producing precise, dosage-form medications, Abbott Laboratories (NYSE:ABT) develops and sells a diverse range of healthcare products including medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals.
Why Are We Positive On ABT?
- Sizeable revenue base of $43.11 billion gives it economies of scale and advantages over new entrants due to the industry’s regulatory complexity
- Share repurchases have increased shareholder returns as its annual earnings per share growth of 10.2% exceeded its revenue gains over the last five years
- Robust free cash flow margin of 16.7% gives it many options for capital deployment
At $131.69 per share, Abbott Laboratories trades at 24.5x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
Stocks We Like Even More
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.